LSTA   $2.9  2.84% Market Closed

Lisata Therapeutics Inc
Total Cash 38.26M
totalCashPerShare 4.599
EBITDA -23.93M
Total Debt 223.00K
quickRatio 8.585
currentRatio 9.418
Total Revenue
debtToEquity 0.587
Revenue/Share
ROA -0.28722998
ROE -0.44030997
grossProfits
freeCashflow -13.25M
operatingCashflow -19.96M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -14.75M
forwardPE -1.0980769
floatShares 6.96M
sharesOutstanding 8.32M
sharesShort 23.81K
sharesShortPriorMonth 13.87K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.19%
heldPercentInstitutions 0.09%
Short Ratio help_outline 1.75%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 4.597
Price To Book help_outline 0.62
earningsQuarterlyGrowth
netIncomeToCommon -21.07M
trailingEps -2.56%
forwardEps -2.60%
enterpriseToEbitda 0.62
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.77 3Q 2024
institutionsCount 24
lastUpdated Nov. 1, 2024, 10:12 p.m.